Insulin by Jet-injection for Hyperglycemia in Diabetes
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the pharmacokinetic and pharmacodynamic profile of
the rapid-acting insulin analogue aspart (Novorapid®) injected subcutaneously by
jet-injection to that of the same insulin injected with a conventional pen in the management
of hyperglycemia in subjects with diabetes